首页> 美国卫生研究院文献>Journal of Translational Medicine >Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury
【2h】

Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury

机译:集成的16S rDNA和元蛋白质组学的新一代测序技术可将健康尿液微生物组与伴有脊髓损伤的神经性膀胱无症状菌尿区分开来

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundClinical dogma is that healthy urine is sterile and the presence of bacteria with an inflammatory response is indicative of urinary tract infection (UTI). Asymptomatic bacteriuria (ABU) represents the state in which bacteria are present but the inflammatory response is negligible. Differentiating ABU from UTI is diagnostically challenging, but critical because overtreatment of ABU can perpetuate antimicrobial resistance while undertreatment of UTI can result in increased morbidity and mortality. In this study, we describe key characteristics of the healthy and ABU urine microbiomes utilizing 16S rRNA gene (16S rDNA) sequencing and metaproteomics, with the future goal of utilizing this information to personalize the treatment of UTI based on key individual characteristics.
机译:背景临床教条是健康的尿液是无菌的,具有炎症反应的细菌的存在指示尿路感染(UTI)。无症状菌尿症(ABU)表示存在细菌但炎症反应可忽略的状态。将ABU与UTI区别开来在诊断上具有挑战性,但至关重要,因为过度治疗ABU可使抗菌素耐药性长期存在,而未充分治疗UTI则可能导致发病率和死亡率增加。在这项研究中,我们描述了利用16S rRNA基因(16S rDNA)测序和元蛋白质组学研究的健康和ABU尿液微生物组的关键特征,未来的目标是利用这些信息根据关键的个体特征对UTI进行个性化治疗。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号